Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne - Université de Bourgogne, Dijon, France; UF Innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne - Université de Bourgogne, Dijon, France; UF Innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Am J Hum Genet. 2022 Aug 4;109(8):1436-1457. doi: 10.1016/j.ajhg.2022.06.011. Epub 2022 Jul 30.
ADGRL1 (latrophilin 1), a well-characterized adhesion G protein-coupled receptor, has been implicated in synaptic development, maturation, and activity. However, the role of ADGRL1 in human disease has been elusive. Here, we describe ten individuals with variable neurodevelopmental features including developmental delay, intellectual disability, attention deficit hyperactivity and autism spectrum disorders, and epilepsy, all heterozygous for variants in ADGRL1. In vitro, human ADGRL1 variants expressed in neuroblastoma cells showed faulty ligand-induced regulation of intracellular Ca influx, consistent with haploinsufficiency. In vivo, Adgrl1 was knocked out in mice and studied on two genetic backgrounds. On a non-permissive background, mice carrying a heterozygous Adgrl1 null allele exhibited neurological and developmental abnormalities, while homozygous mice were non-viable. On a permissive background, knockout animals were also born at sub-Mendelian ratios, but many Adgrl1 null mice survived gestation and reached adulthood. Adgrl1 mice demonstrated stereotypic behaviors, sexual dysfunction, bimodal extremes of locomotion, augmented startle reflex, and attenuated pre-pulse inhibition, which responded to risperidone. Ex vivo synaptic preparations displayed increased spontaneous exocytosis of dopamine, acetylcholine, and glutamate, but Adgrl1 neurons formed synapses in vitro poorly. Overall, our findings demonstrate that ADGRL1 haploinsufficiency leads to consistent developmental, neurological, and behavioral abnormalities in mice and humans.
ADGRL1(拉普罗林 1)是一种特征明确的黏附 G 蛋白偶联受体,其参与突触的发育、成熟和活动。然而,ADGRL1 在人类疾病中的作用一直难以捉摸。在这里,我们描述了 10 名个体,他们具有不同的神经发育特征,包括发育迟缓、智力残疾、注意力缺陷多动障碍和自闭症谱系障碍,以及癫痫,所有这些个体均为 ADGRL1 变异的杂合子。在体外,在神经母细胞瘤细胞中表达的人类 ADGRL1 变体显示出配体诱导的细胞内 Ca 内流调节故障,与杂合不足一致。在体内,Adgrl1 在小鼠中被敲除,并在两种遗传背景下进行了研究。在非允许背景下,携带杂合 Adgrl1 缺失等位基因的小鼠表现出神经和发育异常,而纯合子小鼠则无法存活。在允许背景下,敲除动物的出生率也低于孟德尔比例,但许多 Adgrl1 缺失小鼠能够存活到妊娠,并达到成年。Adgrl1 小鼠表现出刻板行为、性功能障碍、双模态极端运动、增强的惊跳反射和减弱的前脉冲抑制,这些反应对利培酮有反应。体外突触制剂显示多巴胺、乙酰胆碱和谷氨酸的自发释放增加,但 Adgrl1 神经元在体外形成突触的能力较差。总体而言,我们的研究结果表明,ADGRL1 杂合不足会导致小鼠和人类出现一致的发育、神经和行为异常。